AMD drug collaboration

Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents